A randomized, double-blind, controlled dose finding study of NGX-4010 [capsaicin dermal patch] for the treatment of postherpetic neuralgia

Trial Profile

A randomized, double-blind, controlled dose finding study of NGX-4010 [capsaicin dermal patch] for the treatment of postherpetic neuralgia

Completed
Phase of Trial: Phase II/III

Latest Information Update: 16 Apr 2011

At a glance

  • Drugs Capsaicin (Primary)
  • Indications Neuropathic pain; Postherpetic neuralgia
  • Focus Therapeutic Use
  • Sponsors NeurogesX
  • Most Recent Events

    • 16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
    • 02 Sep 2010 Results of a planned pooled analysis of this trial and 3 other RCTs [700005976, 70005965 and 700014824] were presented at the 13th World Congress on Pain.
    • 22 Jul 2010 Results were published in the Journal of Pain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top